Special Report: FDA targets e-cigs that hook teens but don't help smokers quit

E-cigarette makers face an existential threat. By May, they must submit applications to the U.S. Food and Drug Administration proving that their products provide a net benefit to public health. If a company fails to make its case, the FDA has the power to order its products off the market.

FDA under fire for years of delays on e-cigarette regulation

As the FDA pressures e-cigarette firms to stamp out youth vaping, the agency faces criticism itself for failing to rein in the fast-growing industry after years of bureaucratic delays dating back to the Obama administration.

UK ad watchdog bans BAT from Instagram e-cigarette promotion

British American Tobacco (BAT) must stop advertising its e-cigarettes from any public account on Instagram, including some influencers' accounts, the UK's advertising watchdog ruled on Wednesday.

More than 20% of U.S. high school seniors vaped THC in 2019: study

More than 20% of U.S. high school seniors reported vaping marijuana in 2019, the second largest single-year increase in any substance of abuse ever recorded in the annual study of national drug use trends, researchers reported on Wednesday.

Addictive nicotine in Juul nearly identical to a Marlboro: study

The nicotine formula used by controversial e-cigarette maker Juul Labs Inc is nearly identical to the flavor and addictive profile of Altria Group Inc's highly successful Marlboro cigarette brand, new research suggests.

Sustained weight loss in middle-age may lower breast cancer risk

(Reuters Health) - In women over age 50, losing just four pounds and keeping the weight off can lower breast cancer risk, a new study suggests.

Clinic waiting room in Harlem becomes experiment in humanizing medicine

(Reuters Health) - Brightly-colored artwork by patients adorns the walls of the waiting room at a small community healthcare center in New York City, the result of a project by two young doctors on a mission to humanize medicine.

Human exposure to BPA may be greater than previously thought

(Reuters Health) - Humans may be exposed to higher than expected levels of bispehnol A (BPA), a toxic chemical thought to interfere with hormones involved in normal growth and development, according to a study using a new method for measuring the chemical in people.

Patients face difficulty talking about weight with doctors

(Reuters Health) - Doctors rarely talk about weight concerns with patients who are overweight or obese, and when they do, patients' experiences tend to be negative, according to a new review of research based on interviews.

Sacklers withdrew over $10 billion in a decade from Purdue Pharma: New York Times

The Sackler family - owners of Purdue Pharma - transferred more than $10 billion in a decade from the OxyContin maker to its trusts and holding companies, the New York Times reported on Monday, citing a new audit commissioned by the drugmaker.

Biohaven Pharma says treatment for acute migraine succeeds in study

Biohaven Pharmaceutical Holding Company Ltd said on Tuesday two doses of its experimental treatment for acute migraine were effective in reducing headaches in a pivotal study.

Related Videos

Danny Aiello, actor in 'Do the Right Thing,' dies at 86

Star Wars cast tease answers in new film

Introducing the all-new
Reuters News app

The new Reuters News app is here, redesigned from the ground up to fit your busy life.

Get it now on iOS